Effects of Intensive Systolic Blood Pressure Control on Kidney Outcomes in Patients With and Without CKD : A Post Hoc Analysis of SPRINT and ACCORD ‐ BP Trials
Open Access
- 21 October 2025
- journal article
- research article
- Published by Wiley in Journal of Diabetes
- Vol. 17 (10) , e70162
Abstract
Background: The effects of intensive blood pressure (BP) control on adverse kidney outcomes remain undetermined. Methods: This post hoc analysis included the Systolic Blood Pressure Intervention Trial (SPRINT) participants and the Action to Control Cardiovascular Risk in Diabetes Blood Pressure (ACCORD‐BP) participants receiving standard glucose‐lowering treatment and satisfying SPRINT eligibility criteria. The risks of kidney events between intensive (systolic BP < 120 mmHg) and standard (systolic BP < 140 mmHg) controls in participants with or without baseline chronic kidney disease (CKD) were compared using Cox proportional hazards models. Results: A total of 10,946 participants (2724 with CKD and 8222 without CKD) were included. During the intervention and post‐intervention periods, the risk of renal failure was either reduced by intensive BP control in participants with CKD (HR = 0.46; 95% CI = 0.22–0.97) or was not significantly different between intensive and standard BP control in participants without CKD (HR = 0.88, 95% CI = 0.52–1.49; p interaction = 0.128). The risk of ≥ 30% reduction in estimated glomerular filtration rate (eGFR) was increased and the risk of albuminuria was decreased by intensive BP control in participants with or without CKD. Intensive BP control increased the risk of CKD progression to moderate‐ or high‐risk category, but not to very‐high risk category according to the Kidney Disease Improving Global Outcomes (KDIGO) risk categories. Conclusions: The intensive BP control might increase the risk of mild CKD progression but not of more advanced CKD progression or renal failure compared with the standard BP control.Keywords
Funding Information
- National Key Research and Development Program of China (2021YFA1301100, 2021YFC2501600, 2023YFC2506700)
This publication has 33 references indexed in Scilit:
- A Randomized Trial of Intensive versus Standard Blood-Pressure ControlNew England Journal of Medicine, 2015
- Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant dataThe Lancet Diabetes & Endocrinology, 2015
- Evidence Supporting a Systolic Blood Pressure Goal of Less Than 150 mm Hg in Patients Aged 60 Years or Older: The Minority ViewAnnals of Internal Medicine, 2014
- Corrected Data in Table and Clarification of RationaleJAMA, 2014
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice GuidelineAnnals of Internal Medicine, 2013
- Intensive Blood-Pressure Control in Hypertensive Chronic Kidney DiseaseNew England Journal of Medicine, 2010
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes MellitusNew England Journal of Medicine, 2010
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney DiseaseResults From the AASK TrialJAMA, 2002
- The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal DiseaseNew England Journal of Medicine, 1994